Literature DB >> 7710453

Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study.

J Almirall1, I Morató, F Riera, A Verdaguer, R Priu, P Coll, J Vidal, L Murgui, F Valls, F Catalan.   

Abstract

This one year prospective multicentre study was designed to determine the incidence of community-acquired pneumonia in adults. It was carried out in primary health care centres and three reference hospitals, located in the 'Maresme' region (Barcelona, Spain) serving a population of 39,733 subjects over 13 years of age. Patients suspected of having contracted community-acquired pneumonia were visited by their family doctors and referred to the three reference hospitals for confirmation of the diagnosis. Patients attending the emergency services of these hospitals were also included. Urine and blood samples were obtained for culture, antigen detection, blood count, serological tests, blood gases and biochemical profile. The diagnosis of community-acquired pneumonia was made in 105 patients. Forty-six patients had an identifiable microbial etiology. Chlamydia pneumoniae was the most common pathogen (16 cases) followed by Streptococcus pneumoniae (13 cases) and Mycoplasma pneumoniae (8 cases). In conclusion; the annual incidence rate of community-acquired pneumonia in adults in this area was 2.6 cases per 1,000 inhabitants and Chlamydia pneumoniae was the most frequent causative pathogen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7710453

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

1.  Providing better care for patients who may have pneumonia.

Authors:  W F Holmes; M Woodhead
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

Review 2.  Diagnosis of pneumonia and monitoring of infection eradication.

Authors:  M Ruiz; C Arosio; P Salman; T T Bauer; A Torres
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

3.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

4.  Ambulatory community-acquired pneumonia: the predominance of atypical pathogens.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10       Impact factor: 3.267

5.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

6.  Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.

Authors:  Jacques Gaillat; Antoine Flahault; Bertille deBarbeyrac; Jeanne Orfila; Henri Portier; Jean-Pierre Ducroix; Christiane Bébéar; Charles Mayaud
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

7.  Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR.

Authors:  Karolina Gullsby; Martin Storm; Kåre Bondeson
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

8.  Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.

Authors:  J Gómez; V Baños; J Ruiz Gómez; M C Soto; L Muñoz; M L Nuñez; M Canteras; M Valdés
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

9.  Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan.

Authors:  F Blasi; R Cosentini; M C Schoeller; A Lupo; L Allegra
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

10.  Bacteriological and clinical profile of Community acquired pneumonia in hospitalized patients.

Authors:  Bashir Ahmed Shah; Gurmeet Singh; Muzafar Ahmed Naik; Ghulam Nabi Dhobi
Journal:  Lung India       Date:  2010-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.